Free tool
FAERS Monitor: Avalide
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020758 or its brand name (Avalide, Hydrochlorothiazide, Irbesartan). Reports on generic versions are filed under their own applications.
Reports
5,317
Serious
3,023
57% of reports
Hospitalization
1,525
Death reported
277
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea352
- dizziness338
- fatigue308
- drug ineffective298
- dyspnoea246
- headache244
- blood pressure increased217
- diarrhoea216
- hypertension202
- pain195
- vomiting192
- asthenia186
- fall174
- pain in extremity172
- arthralgia164
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 198 |
| 2005 | 271 |
| 2006 | 304 |
| 2007 | 310 |
| 2008 | 351 |
| 2009 | 400 |
| 2010 | 475 |
| 2011 | 742 |
| 2012 | 402 |
| 2013 | 174 |
| 2014 | 165 |
| 2015 | 175 |
| 2016 | 188 |
| 2017 | 137 |
| 2018 | 182 |
| 2019 | 252 |
| 2020 | 128 |
| 2021 | 99 |
| 2022 | 113 |
| 2023 | 73 |
| 2024 | 74 |
| 2025 | 65 |
| 2026 | 39 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,842 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood pressure increasedSignal | 217 | 5.6 | 4.9 | 825 |
| hypertensionSignal | 202 | 3.8 | 3.3 | 413 |
| dizzinessSignal | 338 | 2.7 | 2.4 | 363 |
| pain in extremitySignal | 172 | 2.3 | 2.0 | 128 |
| fallSignal | 174 | 2.1 | 1.8 | 96 |
| asthenia | 186 | 2.0 | 1.7 | 88 |
| nausea | 352 | 1.8 | 1.6 | 119 |
| dyspnoea | 246 | 1.7 | 1.5 | 75 |
| vomiting | 192 | 1.6 | 1.4 | 45 |
| fatigue | 308 | 1.6 | 1.4 | 65 |
| arthralgia | 164 | 1.6 | 1.3 | 33 |
| headache | 244 | 1.5 | 1.4 | 47 |
| diarrhoea | 216 | 1.3 | 1.2 | 17 |
| pain | 195 | 1.3 | 1.1 | 10 |
| drug ineffective | 298 | 0.9 | 0.8 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.